|
3 days to go - register NOW! Informa Life Sciences’ 21st Annual
EU Pharmaceutical Law Forum
22 - 23 May 2012, Hotel le Plaza, Brussels, Belgium
|
This conference provides an unrivalled opportunity for legal professionals working in private practice and in-house counsel to get a complete round-up of the most important legal decisions made over the past 12 months.
This meeting is Europe’s most respected pharmaceutical law conference and has gained a solid reputation for covering the most important topics and attracting THE VERY BEST SPEAKERS.
Please download the conference brochure to see full speaker line up and topics to be presented
DAY ONE:
Competition Law, Anti-Trust and Patent Litigation
DAY TWO:
Stream 1: Regulatory Frameworks in Pharmaceutical Law – EU Pharma Law Package, Pricing and Reimbursement, HTAs, Orphan Drugs, Biosimilars, the Clinical Trials Directive and the Regulatory Frameworks in the Ukraine and Russia
Stream 2: Regulatory Frameworks in Medical Device Law – Post Market Surveillance and Vigilance, Risk Management, Pricing and Reimbursement, HTAs, Clinical Trials and Compliance
Blaž Višnar, European Commission
Jacqueline Minor, European Commission
Vincenzo Salvatore, European Medicines Agency - speaker interview now online!
David Hull, Covington & Burling LLP
Marie Manley, Bristows
Adela Williams, Arnold and Porter
Alexander Denoon, Lawford Davies Denoon
Jordi Faus, Faus and Moliner
Victoria Kitcatt, Pfizer
Helen Roberts, Novartis
Marc Christian Bauer, Amgen
Martin Schwarz, Boehringer Ingelheim
Clive Douglas, Teva Pharmaceuticals
François Garnier, Pfizer
Alexandre Mencik, Amgen
Peter Schroeer, Ethicon-Endo Surgery a Johnson & Johnson Company
Stefan Menzl, Abbott Medical Optics
Alexander Neumann, Sorin Group
Advertising and Social Media in the Pharmaceutical and Medical Device Industries
Led by:
Helen Roberts, Novartis
Vincenzo Salvatore, European Medicines Agency
Heather Simmonds, Prescription Medicines Code of Practice Authority (PMCPA)
Please view the brochure for further details
"An invaluable review of recent developments in EU pharma law and a unique insight into what is coming Partner"
"Very informative with good presentations with very good knowledge"